Weiler Kathy Johnson

SEC source: 0000805928-26-000096 · wk-form4_1786479331.xml · nonDerivative · entry 1

Weiler Kathy Johnson · CIK 0001979466 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 8, 2026.

F2 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $44.43 to $46.47 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0000805928-26-000086 · wk-form4_1782507152.xml · derivative · entry 1

Weiler Kathy Johnson · CIK 0001979466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,392

Underlying: Common Stock · 4,392 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

F2 · derivative.exercise_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $185,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date.

F2 · derivative.expiration_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $185,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date.

SEC source: 0000805928-26-000079 · wk-form4_1782247020.xml · derivative · entry 2

Weiler Kathy Johnson · CIK 0001979466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,150 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

F3 · derivative.exercise_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date.

F3 · derivative.expiration_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date.

SEC source: 0000805928-26-000079 · wk-form4_1782247020.xml · nonDerivative · entry 1

Weiler Kathy Johnson · CIK 0001979466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,150

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This reflects the number of restricted stock units that vested June 19, 2026.

SEC source: 0000805928-26-000069 · wk-form4_1778270855.xml · derivative · entry 3

Weiler Kathy Johnson · CIK 0001979466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,307

Underlying: Common Stock · 16,344 shares

Expires 2033-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option grant for joining the Issuer's Board of Directors. Options vest in three equal annual installments on the annual anniversary of the grant date with the first vesting date occurring on December 20, 2024.

SEC source: 0000805928-26-000069 · wk-form4_1778270855.xml · nonDerivative · entry 2

Weiler Kathy Johnson · CIK 0001979466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $44.04 to $44.26 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0000805928-26-000069 · wk-form4_1778270855.xml · nonDerivative · entry 1

Weiler Kathy Johnson · CIK 0001979466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,344

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000805928-25-000177 · wk-form4_1766006701.xml · derivative · entry 7

Weiler Kathy Johnson · CIK 0001979466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,651

Underlying: Common Stock · 21,825 shares

Expires 2033-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Option grant for joining the Issuer's Board of Directors. Options vest in three equal annual installments on the annual anniversary of the grant date with the first vesting date occurring on December 20, 2024.

SEC source: 0000805928-25-000177 · wk-form4_1766006701.xml · derivative · entry 6

Weiler Kathy Johnson · CIK 0001979466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 18,248 shares

Expires 2034-06-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Non-qualified stock option portion of the annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The grant fully vested on June 6, 2025, the one-year anniversary of the date of the grant.

SEC source: 0000805928-25-000177 · wk-form4_1766006701.xml · nonDerivative · entry 5

Weiler Kathy Johnson · CIK 0001979466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

SEC source: 0000805928-25-000177 · wk-form4_1766006701.xml · nonDerivative · entry 4

Weiler Kathy Johnson · CIK 0001979466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,580

F1 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.01 to $30.00 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0000805928-25-000177 · wk-form4_1766006701.xml · nonDerivative · entry 3

Weiler Kathy Johnson · CIK 0001979466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,405

F1 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.01 to $30.00 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0000805928-25-000177 · wk-form4_1766006701.xml · nonDerivative · entry 2

Weiler Kathy Johnson · CIK 0001979466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,653

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000805928-25-000177 · wk-form4_1766006701.xml · nonDerivative · entry 1

Weiler Kathy Johnson · CIK 0001979466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,828

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000805928-25-000099 · wk-form4_1750450149.xml · derivative · entry 1

Weiler Kathy Johnson · CIK 0001979466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,150

Underlying: Common Stock · 14,150 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

F2 · derivative.exercise_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date.

F2 · derivative.expiration_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date.

SEC source: 0000805928-25-000086 · wk-form4_1749673656.xml · nonDerivative · entry 1

Weiler Kathy Johnson · CIK 0001979466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,580

F1 · acquired: The reported price in Column 4 is a weighted average sale price. These shares were sold on June 9, 2025 in multiple transactions at prices ranging from $10.47 to $10.61 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

SEC source: 0000950170-24-133314 · ownership.xml · nonDerivative · entry 1

Weiler Kathy Johnson · CIK 0001979466 · Chief Comm. & Growth Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,593

F1 · kind: The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on December 2, 2024. The sales were effected through and automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person.

SEC source: 0000950170-24-104169 · ownership.xml · nonDerivative · entry 1

Weiler Kathy Johnson · CIK 0001979466 · Chief Comm. & Growth Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 188,027

F1 · kind: The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on September 1, 2024. The sales were effected through and automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person.

F2 · balance_after: On July 10, 2024, the issuer effected a 1-for-20 reverse split of the issuer's common stock, resulting in proportionate adjustments to the number of shares of Class A common stock beneficially owned by the reporting person, including shares underlying outstanding restricted stock units ("RSUs"). Accordingly, the securities reported on this Form 4 have been adjusted to reflect the 1-for-20 reverse stock split.

SEC source: 0000805928-24-000089 · wk-form4_1718057423.xml · derivative · entry 2

Weiler Kathy Johnson · CIK 0001979466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,248

Underlying: Common Stock · 18,248 shares

Expires 2034-06-06

F2 · derivative.exercise_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 6, 2025, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.

SEC source: 0000805928-24-000089 · wk-form4_1718057423.xml · nonDerivative · entry 1

Weiler Kathy Johnson · CIK 0001979466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,653

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

SEC source: 0000950170-24-069388 · ownership.xml · nonDerivative · entry 1

Weiler Kathy Johnson · CIK 0001979466 · Chief Comm. & Growth Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,905,862

F1 · kind: The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on June 1, 2024. The sales were effected through and automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person.

SEC source: 0000950170-24-019482 · ownership.xml · nonDerivative · entry 1

Weiler Kathy Johnson · CIK 0001979466 · Chief Comm. & Growth Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,975,617

F1 · kind: The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on February 22, 2024. The sales were effected through and automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person.

SEC source: 0000950170-24-018916 · ownership.xml · nonDerivative · entry 1

Weiler Kathy Johnson · CIK 0001979466 · Chief Comm. & Growth Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,258,809

F1 · shares: Represents a grant of restricted stock units, with 25% of the RSUs shall vest two (2) days after the date of grant. The remaining RSUs shall vest in equal increments every three (3) months thereafter (beginning on the first calendar day of the month following the date that is three months following the date of grant) for three (3) years, until such RSU is vested in full on the first day of the calendar month following the three (3) year anniversary of the date of grant.

SEC source: 0000805928-24-000020 · wk-form4_1705011234.xml · derivative · entry 1

Weiler Kathy Johnson · CIK 0001979466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,476

Underlying: Common Stock · 65,476 shares

Expires 2033-12-20

F1 · derivative.exercise_date: Option grant for joining the Issuer's Board of Directors. Options vest in three equal annual installments on the annual anniversary of the grant date with the first vesting date occurring on December 20, 2024.

SEC source: 0001209191-23-034687 · doc4.xml · nonDerivative · entry 2

Weiler Kathy Johnson · CIK 0001979466 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,087,163

SEC source: 0001209191-23-034687 · doc4.xml · nonDerivative · entry 1

Weiler Kathy Johnson · CIK 0001979466 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,351,834

F1 · shares: Represents a grant of restricted stock units, with 25% vesting upon the grant date and the remaining 75% vesting in substantially equal quarterly installments, with the first vest occurring on the 15-month anniversary of the grant date and subsequent vests occurring on each three-month anniversary thereafter until such restricted stock units are fully vested on the four (4) year anniversary of the grant date.